Metformin may boost walking ability in PAD patients, trial finds
NCT ID NCT03054519
First seen Apr 20, 2026 · Last updated May 10, 2026 · Updated 4 times
Summary
This study tested whether taking metformin daily for six months helps people with peripheral artery disease (PAD) walk farther in six minutes. About 200 adults with PAD took either metformin or a placebo. The main goal was to see if metformin improves walking performance, which could ease symptoms and improve daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Ochsner Medical Center
New Orleans, Louisiana, 70121, United States
-
Tulane University
New Orleans, Louisiana, 70112, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Florida
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.